ALDER BIOPHARMACEUTICALS INC Long-Term Debt, Maturity, after Year Five
ALDER BIOPHARMACEUTICALS INC had Long-Term Debt, Maturity, after Year Five of $298.28 million as of 2019-06-30, per its 10-Q filed 2019-08-06.
Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive · last filed 2019-08-06
- 2019-06-30: Long-Term Debt, Maturity, after Year Five $298.28M.
- 2019-03-31: Long-Term Debt, Maturity, after Year Five $298.28M.
- 2018-12-31: Long-Term Debt, Maturity, after Year Five $298.28M.
- 2018-06-30: Long-Term Debt, Maturity, after Year Five $305.47M.
| Period end | Long-Term Debt, Maturity, after Year Five |
|---|---|
| 2019-06-30 | $298.28M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $298.28M 10-Q · filed 2019-05-02 |
| 2018-12-31 | $298.28M 10-K · filed 2019-02-25 |
| 2018-06-30 | $305.47M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $305.47M 10-Q · filed 2018-05-08 |